Glucophage/Glucophage XR Indications/Uses

Glucophage: Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
In adults, Glucophage film-coated tablets may be used as monotherapy or in combination with other oral anti-diabetic agents or with insulin.
In children from 10 years of age and adolescents, Glucophage film-coated tablets may be used as monotherapy or in combination with insulin.
A reduction of diabetic complications has been shown in overweight type 2 diabetic adult patients treated with metformin as first-line therapy after diet failure (see Pharmacology: Pharmacodynamics under Actions).
Glucophage XR: Reduction in the risk or delay of the onset of type 2 diabetes mellitus in adult, overweight patients with IGT* and/or IFG* who are: at high risk for developing overt type 2 diabetes mellitus (see Pharmacology: Pharmacodynamics under Actions) and not suitable for intensive lifestyle modifications.
Treatment with Glucophage XR must be based on a risk score incorporating appropriate measures of glycaemic control and including evidence of high cardiovascular risk (see Pharmacology: Pharmacodynamics under Actions).
*IGT: Impaired Glucose Tolerance; IFG: Impaired Fasting Glucose
Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.
Glucophage XR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.